Company / Cash & Equivalents
Oscar Health, Inc. Cash & Equivalents History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$2.8B
FY2025
5-year range
$826.3M / $2.8B
FY2021-FY2025
Trend
+81.7%
vs FY2024
Sector context
#18 of 148
Health Care
What the data says
Oscar Health, Inc.'s cash & equivalents of $2.8B is higher than 88% of companies in the Health Care sector (FY2025). Improved from $1.6B to $2.8B over the past 2 years.
Based on SEC 10-K filings.
$2.8B in FY2025 with a 5-year CAGR of +27.4%. Top quartile in the Health Care sector.
Improved from $1.6B to $2.8B over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +36.0%
- 5-Year CAGR
- +27.4%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 148This company $2.8B Sector average $1.2B
▼
+135.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +27.4%, indicating consistent growth.
- In FY2025, cash & equivalents increased 81.7% year-over-year.
- Ranks #18 out of 148 companies in the Health Care sector.
- Lowest cash & equivalents in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.8B | +81.7% |
| FY2024 | $1.5B | -2.0% |
| FY2023 | $1.6B | +41.2% |
| FY2022 | $1.1B | +33.6% |
| FY2021 | $826.3M | +0.0% |
| FY2020 | $826.3M | +145.5% |
| FY2019 | $336.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026